Sigmund Silber, MD, PhD Professor of Medicine
FESC, FACC, FAHA
Cardiologist
Congress Presentations 2010-today
70
PLEASE NOTE:
For more congress presentations, please see also the VIDEO Section:
in English language
in German language
69
ESC Congress (European Society of Cardiology)
Munich, 29th of August 2018
Best Poster: M. Keller, M. Rippel, S. Silber:
Side effects of regadenoson replacing adenosine for pharmacological stress tests in real world: prospective evaluation in over 5000 patients
Abstract
68
ESC Congress (European Society of Cardiology)
Munich, 25th of August 2018
Oral Presentation Prof. Silber
Congress Condensed: Coronary Heart Disease
Program
67
American College of Cardiology (ACC)
Orlando, 11th of March 2018
IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS
JACC March 20, 2018 Volume 71, Issue 11
Abstract
Poster
66
18. Annual Congress of NFIC (New Frontiers in Interventional Cardiology)
Krakow, 7th and 8th of December, 2017
Chairman and Oral Presentation Prof. Silber:
Usefulness of pharmacological stress tests with Regadenosone: Experience in over 4000 patients in a cardiology practice in Germany
Program
Letter of Appreciation
65
Annual Congress of the CIAT
(Cardiovascular Intervention Association of Thailand)
Bangkok, 18th of November 2017
Oral Presentation Prof. Silber:
Should all DAPTs post PCI be new P2Y12 ?
Program
64
TCT Congress, Denver, Colorado
29th of October - 2nd of November 2017
Chairman and Oral Presentation Prof. Silber:
Promus Element Everolimus-Eluting Stents: Device Iterations
and Randomized/Registry Outcomes Data in Perspective
Program
63
Annual Congress of the European Society of Cardiology (ESC)
Barcelona, 30th of August 2017
Oral Presentation Prof. Silber:
Congress Condensed - General Cardiology
Coronary Artery Disease
Program
62
Great Minds - Expert Meeting
Budapest, June 23rd 2017
Presentation Prof. Silber:
Old and New Effective Strategies for LDL-Cholesterol Reduction
(Video Duration: 18:46)
61
EuroPCR Kongress
Paris, 17.th of May 2017
Poster Presentation: Okada K, Cutlip DE, Barakat M, Silber S, Erglis A, Honda Y on behalf of the COBRA PzF SHIELD Investigators
Final Optical Coherence Tomography Results from the COBRA PzF SHIELD Trial
Poster
60
International Conference on Nuclear Cardiology and Cardiac CT (ICNC)
Vienna, 9th of May 2017
Poster Presentation: Dr. med. M. Keller and Prof. Dr. S. Silber:
High Safety of Regadenoson for Myocardial Perfusion Imaging in a Cardiology Practice: Experience in over 4000 Patients
Poster
59
TCT Congress, Washington, DC
November 1st 2016
Presentation Prof. Silber:
Didactic Session: The TCT Late Breaking Trials:
Highlights – and my Interpretations – from:
BIO-RESORT (TWENTE III) and BIONICS
(Video Duration: 7:34)
58
TCT Congress, Washington, DC
October 31st 2016
Presentation Prof. Silber:
Can Passive Coatings Make a Difference?
Results With the COBRA PzF NanoCoated Coronary Stent
(ppt file, 3,5MB)
57
ESC Congress (European Society of Cardiology)
Rome, August 2016
Presentation:
Nightmares in Clinical Practice:
To stop or not to stop antiaggregation and or anticoagulation before a procedure
Presentation:
Take Home Message for the Practitioner:
Coronary Heart Disease
56
Annual Meeting of the German Society of Cardiology (DGK)
J.-N. Boeckel, L. Palapies, J. Klotsche, T. Zeller, B. von Jeisen, L. Pieper, S. Tzikas, D. Leistner, C. Bickel, G. K. Stalla, H. Lehnert, S. Silber, S. Baldus, W. März, S. Dimmeler, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller
Presentation: A new method to adjust Troponin I accounting for the confounders age, gender and kidney function facilitates clinical interpretation in patients with chest pain
Mannheim, April 2nd 2016
55
ESC Congress (European Society of Cardiology)
Piccolo R, Heg D, Rat, Franzone JA, Silber S, Serruys PW, Pigrim T, Juni P, Windecker S.
Comparative effectiveness and safety of new versus early generation drug-eluting stents according to the complexity of coronary artery disease. A patient level pooled analysis of 6,081 patients
download presentation
download abstract, European Heart Journal ( 2015 ) 36 ( Abstract Supplement ), 29
London, 29. August 2015
54
Fajadet J, Garcia E, Neumann FJ, Hildick-Smith D, Petronio S, Spence M, Wöhrle J, Zaman A, Elhadad S, Silber S
on behalf of the Platinum Plus Trial Investigators
Results of the Primary Endpoint of the Platinum Plus Trial:
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients
1 year results
TCT (Transcatheter Cardiovascular Therapeutics)
San Francisco, Oktober 2013
Power Point Presentation
53
Symposium:
JIM - Joint Interventional Meeting
Presentations:
Live Case Commentator:
Live cases from Bonn, Germany
Rom, 14. - 15. Februar 2013
52
Fajadet J, Garcia E, Hildick-Smith D, Petronio S, Silber S, Neumann FJ, Zaman A, Wöhrle J, Spence M, Elhadad S
on behalf of the Platinum Plus Trial Investigators
A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients: PLATiNUM PLUS
1 month results
TCT (Transcatheter Cardiovascular Therapeutics)
Miami, October 2012
Poster Presentation
51
XXXIV Congresso DA SBHCI 2012
Novas fronteiras - O tratamento do doença arterial coronariana com balao farmacológico
Vortrag: Vaelentines Trial I. o balão farmacologico é uma opção ao BMS e DES nos casos restenose intra stent?
Salvador, Brasil, 20. June 2012
50
TCT Russia
Chair: Use of DES in Specific Clinical Scenarios
Moderator: Thrombus Management in STEMI- MGuard™ Late Breaking Data.
Moderator: Emerging Coronary Devices
Presentation: Clinical update on Paclitaxel-coated balloon formulations: are there alternatives to lopromide-based coatings?
Moskow, Russia, 28. - 30. Mai 2012
49
ACS MasterClass Munich:
Presentation: The 2010 ESC Guidelines on Myocardial Revascularization:
A critical review
Munich, 7th of July 2011
48
XXI. Workshop of Interventional Cardiology:
Presentation: The Resolute Clinical Programme: Current Status
Hradec Králové, Czech Republic, 8. April 2011
47
RSICA Congress:
Plenary Session: "New generation of DES, DEB and Bioabsorbable stents".
Vortrag: As an Interventional Cardiologist, which DES would you like to have in your arteries?Plenary Session: Modern Interventional Cardiology and Angiology
Vortrag: Evolution in management of in-stent-restenosis. DEB.
Moskow, Russia, 21. March 2011
46
Cardiology Update 2011
Revascularisation, ACS, Antithrombotics
Satellite Symposium
Presentation: Convincing New Stent Developments
Davos, Switzerland, 17. February 2011
45
Symposium:
JIM - Joint Interventional Meeting
Live Case Commentator
Life Cases from Milan, Italy
Life Cases from Essen, Germany
Rome, Italy, 10.-11. Februayr 2011
44
ICI Congress
Drug Eluting Balloons
Chairman:
Drug Eluting Balloons (cont.)
Presentation: Dior in Coronary Intervention
Lunch Symposium: MGuard, New Evidence in Acute MI
Panel
Regulation in the Changing Economic and Ethical Environment
Presentation: DES: New Recommendations of the ESC
Tel Aviv, Israel, 7. December 2010
43
EuroPCR Symposium
What do Resolute All Comers Data tell us about the treatment of complex patients and complex lesions?
Chairman,
Presentation: Challenges in treating complex lesions: What answers does the Resolute All Comers trial provide?
Paris, France, 27. May 2010
42
Euro PCR
Evening Symposium
MGuard - two Years Experience in Acute MI
Panel
Paris, France, 26. May 2010
41
59th ESCVS International Congress
in conjunction with the 6th Congress of update in Cardiology and Cardiovascular Surgery - Heart and Health Foundation of Turkey (HHFT)
Lunch Symposium
IAIC Session
Drug Eluting Stents: A new paradigm in interventionell cardiology
Presentations:
- Transferability of data between different drug eluting stens
- STEMI: Early intervention-Thrombus aspiration
Izmir, Turkey, 17. April 2010
40
ACC
Coronary Artery Disease
Panel Discussion
Atlanta, USA, 14. March 2010